TrialContemporary clinical trials2023

REFINE (REduced Frequency ImmuNE checkpoint inhibition in cancers): A multi-arm phase II basket trial testing reduced intensity immunotherapy across different cancers.

Sophie Merrick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.